While the world focuses on COVID-19, this article provides insight on the current state of the market for antimicrobial resistant (AMR) medicines.
Philip Chu, PhD
Advertisement
Articles by Philip Chu, PhD
Advertisement
Latest Updated Articles
- A Market Failure for Antimicrobial Resistant Medicines
Published: July 8th 2020 | Updated:
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
